These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7454926)

  • 1. A cognitive impairment scale applicable to verbal samples and its possible use in clinical trials in patients with dementia [proceedings].
    Gottschalk LA; Eckardt MJ; Cohn JB; Terman SA; Wolf RJ
    Psychopharmacol Bull; 1980 Oct; 16(4):25-7. PubMed ID: 7454926
    [No Abstract]   [Full Text] [Related]  

  • 2. Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia.
    Krishnan KR; Levy RM; Wagner HR; Chen G; Gersing K; Doraiswamy PM
    Psychopharmacol Bull; 2001; 35(3):79-88. PubMed ID: 12397880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 4. The Mini-SIB: a short scale for measuring cognitive function in severe dementia.
    Qazi A; Richardson B; Simmons P; Mullan E; Walker Z; Katona C; Orrell M
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):1001-2. PubMed ID: 16173007
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychocognitive impairment evaluation in early post-stroke period].
    Naconecinîi D; Prodan MR; Leca-Radu E; Indrei A; Stefanache F
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):947-50. PubMed ID: 20209767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation and mild cognitive impairment: what correlation?
    Puccio D; Novo G; Baiamonte V; Nuccio A; Fazio G; Corrado E; Coppola G; Muratori I; Vernuccio L; Novo S
    Minerva Cardioangiol; 2009 Apr; 57(2):143-50. PubMed ID: 19274024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives.
    Arlt S; Hornung J; Eichenlaub M; Jahn H; Bullinger M; Petersen C
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):604-10. PubMed ID: 18008392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and tolerance of long-term naftidrofuryl treatment of patients with senile dementia. Controlled study versus placebo].
    Cucinotta D; Dall'Asta D; Benaglia F; Ciotti G; Nicora M; Passeri M
    G Clin Med; 1987 Apr; 68(4):211-7. PubMed ID: 3301493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of behavioural and psychotic symptoms and functional status of nursing home residents with a diagnosis of dementia].
    Bidzan L; Bidzan M
    Psychiatr Pol; 2006; 40(5):833-43. PubMed ID: 17217229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive rehabilitation in patients with mild cognitive impairment.
    Kurz A; Pohl C; Ramsenthaler M; Sorg C
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):163-8. PubMed ID: 18636436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
    Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visuospatial learning in dementia and depression].
    Radziwiłłowicz W
    Psychiatr Pol; 2004; 38(2):263-82. PubMed ID: 15307292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic interventions in dementia 1: cognitive symptoms and function.
    Taylor C; Dening KH; Duncan A; Kendall T
    Nurs Times; 2009 Jan 13-19; 105(1):16-7. PubMed ID: 19330983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of clinically significant depressive symptoms in an epidemiologic sample of community-dwelling elders with milder forms of cognitive impairment in Hong Kong SAR.
    Chan SS; Lam LC; Tam CW; Lui VW; Chan WC; Wong S; Wong A; Tham MK; Ho KS; Chan WM; Chiu HF
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):611-7. PubMed ID: 18041794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
    Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
    Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.